Illumina (ILMN) News Today: Latest Market and Industry Updates
212.04
4.38
2.11 %
Real-time price
13:42
USD
Daily range
205.35
215.41
215.41
Weekly range
205.79
242.77
242.77
Illumina stock falls nearly 8% as technical weakness fuels heavy selling pressure
Illumina, Inc. (ILMN) fell 7.7% after selling pressure intensified, with bears controlling early price action against the backdrop of the latest operational milestone. The move is supported by ...
Why is Illumina stock up 4.9% today?
Illumina, Inc. (ILMN) advanced 4.94% following its selection for Singapore’s SG-INSIGHT whole-genome sequencing project and recent positive earnings guidance. The move looks limited, as the ...
Illumina stock falls over 12% as weak growth outlook and China business weigh on results
Illumina, Inc. (ILMN) fell 12.2% after its latest earnings results and forward guidance, with growth outlook concerns and issues related to its China business working against otherwise strong ...
What's behind Illumina's latest stock surge?
Illumina, Inc. (ILMN) jumped 6.04% today after reporting strong second-quarter earnings and launching new AI genomic analysis tools, sparking heightened demand. The steep upmove comes as shares ...
ILMN slides nearly 6% as overbought conditions and debt refinancing weigh on sentiment
Illumina, Inc. (ILMN) fell 5.71% today after opening with an upside gap, as investors responded to recent quarterly revenue gains and clinical adoption news. The sharp pullback contradicts the ...
Why is Illumina stock up 5.3% today?
Illumina, Inc. (ILMN) surged 5.32% today as technical momentum and bullish buying pressure powered shares higher. This advance is supported by the stock’s strong position above short-, medium-, ...
Grail wins FDA panel backing for cancer blood test despite efficacy concerns
Regulatory scrutiny is intensifying for multi-cancer early detection tools as Grail moves closer to a U.S. approval decision for its blood-based screening test. An FDA advisory panel backs the ...
Illumina shares extend rally as earnings recovery supports biotech outperformance
Illumina is continuing to climb even as broader market sentiment remains focused on interest rates, AI and uneven biotech performance. The advance follows a long period of regulatory setbacks, ...
What's behind Illumina's latest 3.3% stock surge?
Illumina, Inc. (ILMN) surged 3.26% today as renewed optimism followed its re-inclusion in the S&P 500 and confirmation of sustained earnings growth. The move is supported by strong upward ...
Why is Illumina stock up 3.1% today?
Illumina, Inc. (ILMN) surged 3.19% after new institutional buying and an upbeat Q2 revenue report fueled investor demand. The advance is reinforced by the stock trading firmly above all key moving ...
Why is Illumina stock up 7.1% today?
Illumina, Inc. (ILMN) surged 7.16% after issuing $300 million in new notes, boosting its liquidity as investors react positively to a fresh funding round. The bullish structure is reinforced by ...
Illumina stock rises nearly 4% as earnings beat forecasts and bullish momentum builds
Illumina, Inc. (ILMN) rose 3.68% after reporting stronger-than-expected quarterly revenue and raising full-year earnings guidance, driving renewed buying interest. The move is supported by the ...
Illumina stock drops 2.51% as upside meets heavy resistance near $178.01
Illumina (ILMN) stock is trading at $176.56 after a daily drop of 2.51%. The price finished near session lows, now below its short-term moving averages but above ...
Selling pressure pushes Illumina stock lower in today's trading
Illumina, Inc. (ILMN) dropped 2.04% after Roche launched a new next-generation gene sequencing machine aimed at competing with Illumina's market position. The move faces limits, with bullish ...
